Cited by 171Schizophrenia research and treatmentSubstance Abuse Treatment and OutcomesHomelessness and Social Issues

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

The impact of substance use disorders on the course of schizophrenia—A 15-year follow-up study

Schmidt, Lasse M., Hesse, Moten, Lykke, Jørn·2011·Schizophrenia Research

DOI 10.1016/j.schres.2011.04.011

Open this paper in CoChat — free account

Abstract

Background This follow-up study compared patients with schizophrenia with co-occurring substance use disorder to patients with schizophrenia and no substance use disorder.Aims To investigate the prognostic significance of the effects of substance use disorders on the course of schizophrenia.Method Patients with schizophrenia and co-occurring substance use disorder (n=107), and patients with schizophrenia only (n=119) were followed over a 15-year period through the use of national hospitalization registers, data for time and cause of death, and data for homelessness or institutionalization.Results The median length of psychiatric hospitalization was 12 days for a patient with dual diagnosis, and 21 days for patients with schizophrenia only. Patients with dual diagnosis displayed a significantly elevated usage of all types of hospital contacts except inpatient treatment for non-psychiatric disorders. In three types of hospital contacts, patients with co-occurring substance use had approximately two to three times as many hospitalizations as did patients with schizophrenia only. Rates for homelessness and institutionalization were similar in both groups. Patients with a dual diagnosis were also significantly more at risk of dying during follow-up than were patients with schizophrenia only.Conclusions The findings suggest that the long-term course of schizophrenia is considerably more severe in patients who have a dual diagnosis compared to patients with schizophrenia only Substance use disorders have a substantial impact on the hospitalization rates of patients with schizophrenia, as well as on life expectancy. Patients with co-morbid substance abuse are more likely to be admitted for treatment during a given year although they have briefer contact with treatment.

Integrity signals

Registry

Crossref · 10.1016/j.schres.2011.04.011

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Psychiatric Comorbidities and Schizophrenia
Buckley, P. F., Miller, B. J., Lehrer, D. S., & Castle, D. J. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn135 · Cited by 1,121
Substance Use Disorders in Schizophrenia--Clinical Implications of Comorbidity
Volkow, N. D. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp016 · Cited by 272
Work, Recovery, and Comorbidity in Schizophrenia: A Randomized Controlled Trial of Cognitive Remediation
McGurk, S. R., Mueser, K. T., DeRosa, T., & Wolfe, R. S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn182 · Cited by 271
Psychosocial Treatments for People with Co-occurring Severe Mental Illnesses and Substance Use Disorders (Dual Diagnosis): A Review of Empirical Evidence
Horsfall, J. M., Cleary, M. L., Hunt, G. E., & Walter, G. (2009) · Harvard Review of Psychiatry · doi:10.1080/10673220902724599 · Cited by 236
Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample.
Kavanagh, D., Waghorn, G., Jenner, L., Chant, D., Carr, V., Evans, M., Herrman, H., Jablensky, A., & McGrath, J. (2004) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00130-0 · Cited by 200
Ten-Year Recovery Outcomes for Clients With Co-Occurring Schizophrenia and Substance Use Disorders
Drake, R. E., McHugo, G. J., Xie, H., Fox, M., Packard, J. D., & Helmstetter, B. S. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj064 · Cited by 150
A multicentre inter-rater reliability study using the OPCRIT computerized diagnostic system
Williams, J. H., FARMER, A. E., Ackenheil, M., Kaufmann, C. A., & McGuffin, P. (1996) · Psychological Medicine · doi:10.1017/s003329170003779x · Cited by 135
The revolving door phenomenon in psychiatry: comparing low-frequency and high-frequency users of psychiatric inpatient services in a developing country
Botha, U. A., Koen, L., Joska, J. A., Parker, J. S., Horn, N. R., Hering, L., & Oosthuizen, P. P. (2009) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-009-0085-6 · Cited by 129
Assessment and Treatment Selection for “Revolving Door” Inpatients with Schizophrenia
Weiden, P. J., & Glazer, W. M. (1997) · Psychiatric Quarterly · doi:10.1023/a:1025499131905 · Cited by 121
Risk Factors for Violent Crime in Schizophrenia
Fazel, S., Grann, M., Carlström, E. L., Lichtenstein, P., & Långström, N. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04274 · Cited by 108

Flagged first, then by citations

Show all 16 references

Sorted by citations

Excess early mortality in schizophrenia.
Laursen, T. M., Nordentoft, M., & Mortensen, P. B. (2014) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032813-153657 · Cited by 913
Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990–2017: Systematic review and meta-analysis
Hunt, G. E., Large, M. M. B., Cleary, M. L., Lai, H. M. X., & Saunders, J. B. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.07.011 · Cited by 483
Life expectancy and cardiovascular mortality in persons with schizophrenia
Laursen, T. M., Munk-Olsen, T., & Vestergaard, M. (2012) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32835035ca · Cited by 518
Psychosocial Treatments for Schizophrenia
Mueser, K. T., Deavers, F. E., Penn, D. L., & Cassisi, J. E. (2013) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050212-185620 · Cited by 423
Psychosocial Interventions for People With Both Severe Mental Illness and Substance Misuse
Hunt, G. E., Siegfried, N., Morley, K. C., Sitharthan, T., & Cleary, M. L. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt160 · Cited by 282
Schizophrenia--Time to Commit to Policy Change
Fleischhacker, W. W., Arango, C., Arteel, P., Barnes, T. R. E., Carpenter, W., Duckworth, K., Galderisi, S., Halpern, L., Knapp, M., Marder, S. R., et al. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu006 · Cited by 214
Frequency of health‐care utilization by adults who use illicit drugs: a systematic review and meta‐analysis
Lewer, D., Freer, J., King, E., Larney, S., Degenhardt, L. J., Tweed, E., Hope, V. D., Harris, M., Millar, T., Hayward, A. C., et al. (2019) · Addiction · doi:10.1111/add.14892 · Cited by 179
Mortality in Schizophrenia and Other Psychoses: A 10-Year Follow-up of the ӔSOP First-Episode Cohort
Reininghaus, U., Dutta, R., Dazzan, P., Doody, G. A., Fearon, P., Lappin, J., Heslin, M., Onyejiaka, A., Donoghue, K., Lomas, B., et al. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu138 · Cited by 156
Psychosocial interventions for people with both severe mental illness and substance misuse
Hunt, G. E., Siegfried, N., Morley, K. C., Sitharthan, T., & Cleary, M. L. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001088.pub3 · Cited by 125
Canadian Schizophrenia Guidelines: Schizophrenia and Other Psychotic Disorders with Coexisting Substance Use Disorders
Crockford, D. N., & Addington, D. E. (2017) · The Canadian Journal of Psychiatry · doi:10.1177/0706743717720196 · Cited by 113
Causes of mortality in schizophrenia: an updated review of European studies
Department of Psychiatry, W. M. U., Piotrowski, P., M. Gondek, T., Department of Psychiatry, W. M. U., Królicka-Deręgowska, A., Department of Psychiatry, W. M. U., Misiak, B., Department of Genetics, W. M. U., Adamowski, T., Department of Nervous System Diseases, F. O. H. S., et al. (2017) · Psychiatria Danubina · doi:10.24869/psyd.2017.108 · Cited by 107
“Apart from schizophrenia, they also analysed mortality in people diagnosed with: substance abuse (Chang et al. 2010, Schmidt et al. 2011), affective disorder (Laursen et al. 2009, Chang et al. 2010, Laursen et al. 2011, Laursen 2011, Hoang et al. 2011, Hoang et al. 2013), schizoaffective disorder…”
BackgroundInfluential
Psychosocial interventions for people with both severe mental illness and substance misuse
Hunt, G. E., Siegfried, N., Morley, K., Brooke-Sumner, C., & Cleary, M. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001088.pub4 · Cited by 105
Treatment of Co-Occurring Psychotic and Substance Use Disorders
Mueser, K. T., & Gingerich, S. L. (2013) · Social Work in Public Health · doi:10.1080/19371918.2013.774676 · Cited by 86
Total and cause-specific standardized mortality ratios in patients with schizophrenia and/or substance use disorder
Heiberg, I. H., Jacobsen, B. K., Nesvåg, R., Bramness, J. G., Reichborn‐Kjennerud, T., Næss, Ø., Ystrøm, E., Hultman, C. M., & Høye, A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202028 · Cited by 94
The Effect of Substance Use on 10-Year Outcome in First-Episode Psychosis
Weibell, M. A., Hegelstad, W. T. V., Auestad, B., Bramness, J. G., Evensen, J. H., Haahr, U., Joa, I., Johannessen, J. O., Larsen, T. K., Melle, I. S., et al. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw179 · Cited by 81
Morbidity and mortality in schizophrenia with comorbid substance use disorders
Lähteenvuo, M., Batalla, A., Luykx, J. J., Mittendorfer‐Rutz, E., Tanskanen, A. J., Tiihonen, J., & Taipale, H. T. (2021) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13291 · Cited by 78
Mortality, cause of death and risk factors in patients with alcohol use disorder alone or poly-substance use disorders: a 19-year prospective cohort study
Hjemsæter, A. J., Bramness, J. G., Drake, R. E., Skeie, I., Monsbakken, B., Benth, J. Š., & Landheim, A. S. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2077-8 · Cited by 71
Clinical presentations and diagnostic issues in dual diagnosis disorders
Morojele, N. K., Saban, A., & Seedat, S. (2012) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328351a429 · Cited by 63
Mortality and Its Determinants in People With Psychotic Disorder
Suvisaari, J., Partti, K., Perälä, J., Viertiö, S., Saarni, S. E., Lönnqvist, J. K., Saarni, S. I., & Härkänen, T. (2012) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31827ad512 · Cited by 66
Childhood maltreatment and transition to psychotic disorder independently predict long-term functioning in young people at ultra-high risk for psychosis
Yung, A. R., Cotter, J., Wood, S. J., McGorry, P. D., Thompson, A. D., Nelson, B., & Lin, A. P. (2015) · Psychological Medicine · doi:10.1017/s003329171500135x · Cited by 57
Cariprazine (RGH-188), a D3-preferring dopamine D3/D2 receptor partial agonist antipsychotic candidate demonstrates anti-abuse potential in rats
Román, V., Gyertyán, I., Sághy, K., Kiss, B., & Szombathelyi, Z. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2906-7 · Cited by 56
Cognitive Enhancement Therapy in substance misusing schizophrenia: Results of an 18-month feasibility trial
Eack, S. M., Hogarty, S. S., Greenwald, D. P., Litschge, M. Y., McKnight, S. A. F., Bangalore, S. S., Pogue‐Geile, M. F., Keshavan, M. S., & Cornelius, J. R. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.11.017 · Cited by 56
Executive functioning in men with schizophrenia and substance use disorders: influence of lifetime suicide attempts
Adan, A., Capella, M. D. M., Prat, G., Forero, D. A., López-Vera, S., & Navarro, J. F. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169943 · Cited by 50
Refining and integrating schizophrenia pathophysiology – Relevance of the allostatic load concept
Misiak, B., Frydecka, D., Zawadzki, M., Krefft, M., & Kiejna, A. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.06.004 · Cited by 47
Factors and their weight in reducing life expectancy in schizophrenia
Correll, C. U., Bitter, I., Hoti, F. J., Mehtälä, J., Wooller, A., Pungor, K., & Tiihonen, J. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2022.10.019 · Cited by 44
Light alcohol intake during adolescence induces alcohol addiction in a neurodevelopmental model of schizophrenia
Jeanblanc, J., Balguerie, K., Coune, F., Legastelois, R., Jeanblanc, V., & Naassïla, M. (2014) · Addiction Biology · doi:10.1111/adb.12146 · Cited by 40
Health outcomes and service use patterns associated with co‐located outpatient mental health care and alcohol and other drug specialist treatment: A systematic review
Glover‐Wright, C., Coupe, K., Campbell, A. C., Keen, C., Lawrence, P., Kinner, S. A., & Young, J. T. (2023) · Drug and Alcohol Review · doi:10.1111/dar.13651 · Cited by 41
Reactivity to addictive drugs in the methylazoxymethanol (MAM) model of schizophrenia in male and female rats
Kučerová, J., Babinská, Z., Amchová, P., Štark, T., Drago, F., Šulcová, A., & Micale, V. (2016) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2016.1190032 · Cited by 38
The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability
Løberg, E., Helle, S., Nygård, M., Berle, J. Ø., Kroken, R. A., & Johnsen, E. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00159 · Cited by 40
Antisocial personality disorder in people with co-occurring severe mental illness and substance use disorders: clinical, functional, and family relationship correlates
Mueser, K. T., Gottlieb, J. D., Cather, C., Glynn, S. M., Zárate, R., Smith, M. F., Clark, R. E., & Wolfe, R. S. (2011) · Psychosis · doi:10.1080/17522439.2011.639901 · Cited by 36
Psychosis, Mania and Criminal Recidivism: Associations and Implications for Prevention
Lamberti, J. S., Katsetos, V., Jacobowitz, D. B., & Weisman, R. L. (2020) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000251 · Cited by 40
Factors Leading African Americans and Black Caribbeans to Use Social Work Services for Treating Mental and Substance Use Disorders
Cheng, T. C., & Robinson, M. A. (2013) · Health & Social Work · doi:10.1093/hsw/hlt005 · Cited by 37
Schizophrenia is associated with increased risk of subsequent substance abuse diagnosis: A nation‐wide population‐based register study
Petersen, S. M., Toftdahl, N. G., Nordentoft, M., & Hjorthøj, C. R. (2019) · Addiction · doi:10.1111/add.14746 · Cited by 34
From apathy to addiction: Insights from neurology and psychiatry
Kirschner, M., Rabinowitz, A. G., Singer, N., & Dagher, A. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109926 · Cited by 37
Once-Monthly Long-Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co-occurring Substance Use Disorders: A Multicentre, Observational Study
Szerman, N., Basurte-Villamor, I., Vega, P., Martı́nez-Raga, J., Parro-Torres, C., Almerge, J. C., Grau‐López, L., Matteis, M. D., & Árias, F. (2020) · Drugs - Real World Outcomes · doi:10.1007/s40801-020-00178-8 · Cited by 32
Associations between antipsychotic use, substance use and relapse risk in patients with schizophrenia: real-world evidence from two national cohorts
Lähteenvuo, M., Luykx, J. J., Taipale, H. T., Mittendorfer‐Rutz, E., Tanskanen, A. J., Batalla, A., & Tiihonen, J. (2022) · The British Journal of Psychiatry · doi:10.1192/bjp.2022.117 · Cited by 30
The Developmental Origins of Opioid Use Disorder and Its Comorbidities
Levis, S. C., Mahler, S. V., & Baram, T. Z. (2021) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2021.601905 · Cited by 33
Management of schizophrenia and comorbid substance use disorders: expert review and guidance
Neyra, A., Parro-Torres, C., Ros‐Cucurull, E., Machado, I. C., Echarri, E., & Torrens, M. (2024) · Annals of General Psychiatry · doi:10.1186/s12991-024-00529-7 · Cited by 28
Comorbidity Between Psychiatric Diseases and Alcohol Use Disorders: Impact of Adolescent Alcohol Consumption
Jeanblanc, J. (2015) · Current Addiction Reports · doi:10.1007/s40429-015-0076-5 · Cited by 29
Neurobiological underpinnings and modulating factors in schizophrenia spectrum disorders with a comorbid substance use disorder: A systematic review
Adán, A., Arredondo, A. Y., Capella, M. D. M., Prat, G., Forero, D. A., & Navarro, J. F. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.01.038 · Cited by 29
Effects of a Brief Intervention for Substance Use on Tobacco Smoking and Family Relationship Functioning in Schizophrenia and Related Psychoses: A Randomised Controlled Trial
Tantirangsee, N., Assanangkornchai, S., & Marsden, J. (2014) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2014.10.011 · Cited by 25
Prevention and Recovery in Early Psychosis (PREP®): Building a public-academic partnership program in Massachusetts, United States
Caplan, B., Zimmet, S. V., Meyer, E. C., Friedman‐Yakoobian, M. S., Monteleone, T., Leung, Y. J., Guyer, M. E., Rood, L. L., Keshavan, M. S., & Seidman, L. J. (2013) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2012.10.009 · Cited by 25
Drug-related predictors of readmission for schizophrenia among patients admitted to treatment for drug use disorders
Thomsen, K. R., Thylstrup, B., Pedersen, M. M., Pedersen, M. U., Simonsen, E. H., & Hesse, M. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.09.026 · Cited by 25
Self-citation
Challenges in working with patients with dual diagnosis
Pinderup, P. (2018) · Advances in Dual Diagnosis · doi:10.1108/add-11-2017-0021 · Cited by 24
Course, remission and recovery in patients with severe psychotic disorders with or without comorbid substance use disorders: Long-term outcome in evidence-based integrated care (ACCESS II study)
Ruppelt, F., Rohenkohl, A. C., Kraft, V., Schöttle, D., Schröter, R., Gaianigo, J., Werkle, N., Daubmann, A., Karow, A., & Lambert, M. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.03.058 · Cited by 24
Opiate Dependence in Schizophrenia: Case Presentation and Literature Review
Kern, A., Akerman, S. C., & Nordstrom, B. R. (2013) · Journal of Dual Diagnosis · doi:10.1080/15504263.2013.867199 · Cited by 23
Making meaning of multimorbidity and severe mental illness: A viewpoint
Halstead, S., Siskind, D. J., & Warren, N. (2023) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/00048674231195560 · Cited by 21
Improving the Knowledge, Attitudes, and Practices of Mental Health Professionals Regarding Dual Diagnosis Treatment – a Mixed Methods Study of an Intervention
Pinderup, P. (2018) · Issues in Mental Health Nursing · doi:10.1080/01612840.2017.1398791 · Cited by 20
Functioning in patients with schizophrenia: A multicentre study evaluating the clinical perspective
Barrios, M., Gómez‐Benito, J., Pino, Ó., Rojo, E., & Guilera, G. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.05.079 · Cited by 20
Polysubstance addiction vulnerability in mental illness: Concurrent alcohol and nicotine self‐administration in the neurodevelopmental hippocampal lesion rat model of schizophrenia
Sentir, A. M., Bell, R. L., Engleman, E. A., & Chambers, R. A. (2018) · Addiction Biology · doi:10.1111/adb.12704 · Cited by 19
Cortical thickness, cortical surface area and subcortical volumes in schizophrenia and bipolar disorder patients with cannabis use
Hartberg, C. B., Lange, E. H., Lagerberg, T. V., Haukvik, U. K., Andreassen, O. A., Melle, I. S., & Agartz, I. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.11.019 · Cited by 18
Personality Traits in Individuals with the Dual Diagnosis of Psychosis and Substance Use Disorders: A Comprehensive Review and Meta-Analysis
오현주, Jang, S.-K., Lee, H.-S., Lee, E., & Choi, K. (2021) · Journal of Dual Diagnosis · doi:10.1080/15504263.2020.1839827 · Cited by 19
Using rodents to model schizophrenia and substance use comorbidity
Ng, E., McGirr, A., Wong, A. H. C., & Roder, J. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.03.025 · Cited by 19
Research landscape analysis on dual diagnosis of substance use and mental health disorders: key contributors, research hotspots, and emerging research topics
Sweileh, W. M. (2024) · Annals of General Psychiatry · doi:10.1186/s12991-024-00517-x · Cited by 17
Predicting factors for non-suicidal self-injury in patients with schizophrenia spectrum disorders and the role of substance use
Güney, E., Alnıak, İ., & Erkıran, M. (2020) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2020.102068 · Cited by 17
Meta-Analysis on the Effect of Contingency Management for Patients with Both Psychotic Disorders and Substance Use Disorders
Destoop, M., Docx, L., Morrens, M., & Dom, G. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040616 · Cited by 17
Comorbid Alcohol, Cannabis, and Cocaine Use Disorders in Schizophrenia: Epidemiology, Consequences, Mechanisms, and Treatment
Addy, P. H., Radhakrishnan, R., Cortés, J. A., & D’Souza, D. C. (2012) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.10.2.140 · Cited by 17
Cognitive Enhancement Therapy Improves Frontolimbic Regulation of Emotion in Alcohol and/or Cannabis Misusing Schizophrenia: A Preliminary Study
Wojtalik, J. A., Hogarty, S. S., Cornelius, J. R., Phillips, M. L., Keshavan, M. S., Newhill, C. E., & Eack, S. M. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00186 · Cited by 16
Supporting recovery in social work with persons having co-occurring problems – clients’ and professionals’ perceptions
von Greiff, N., Skogens, L., & Topor, A. (2018) · Nordic Social Work Research · doi:10.1080/2156857x.2018.1520739 · Cited by 16
Temperament and Character Profile and Its Clinical Correlates in Male Patients with Dual Schizophrenia
Río-Martínez, L., Marquez-Arrico, J. E., Prat, G., & Adán, A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061876 · Cited by 16
Substance use among Danish psychiatric patients: a cross-sectional study
Sørensen, T. M., Jespersen, H. S. R., Vinberg, M., Becker, U., Ekholm, O., & Fink‐Jensen, A. (2017) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2017.1400098 · Cited by 15
Prevalence and clinical correlates of substance use amongst acute psychiatric inpatients in Gauteng, South Africa
Anic, A., & Robertson, L. J. (2020) · South African Journal of Psychiatry · doi:10.4102/sajpsychiatry.v26i0.1526 · Cited by 15
Schizophrenia and drug addiction comorbidity: recent advances in our understanding of behavioural susceptibility and neural mechanisms
Menne, V., & Chesworth, R. (2020) · Neuroanatomy and Behaviour · doi:10.35430/nab.2020.e10 · Cited by 15
Essential Elements of Forensic Assertive Community Treatment
Lamberti, J., & Weisman, R. (2021) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000299 · Cited by 12
Schizophrenia and oral health: Review of the literature
Đorđević, V., Đukić-Dejanović, S., Janković, L., & Todorović, L. (2016) · Balkan Journal of Dental Medicine · doi:10.1515/bjdm-2016-0002 · Cited by 15
Mobile cognitive testing in patients with schizophrenia: A controlled study of feasibility and validity
Dupuy, M., Misdrahi, D., N’Kaoua, B., Tessier, A., Bouvard, A., Schweitzer, P., Auriacombe, M., Serre, F., Fatseas, M., & Swendsen, J. D. (2018) · Journal de Thérapie Comportementale et Cognitive · doi:10.1016/j.jtcc.2018.02.002 · Cited by 14
Training Changes Professionals’ Attitudes Towards Dual Diagnosis
Pinderup, P. (2016) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-016-9649-3 · Cited by 14
Psychiatric Hospitalizations of Chronic Psychotic Disorder Patients With and Without Dual Diagnosis, Israel, 1963–2016
Florentin, S., Rosca, P., Raskin, S., Bdolah‐Abram, T., & Neumark, Y. D. (2019) · Journal of Dual Diagnosis · doi:10.1080/15504263.2019.1609149 · Cited by 14
Critical Review of Dual Diagnosis Training for Mental Health Professionals
Pinderup, P., Thylstrup, B., & Hesse, M. (2016) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-016-9665-3 · Cited by 13
Self-citation
Comorbid opioid use is undertreated among forensic patients with schizophrenia
Kivimies, K., Repo‐Tiihonen, E., Kautiainen, H., & Tiihonen, J. (2018) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-018-0177-y · Cited by 13
Incremental predictive validity of the Addiction Severity Index psychiatric composite score in a consecutive cohort of patients in residential treatment for drug use disorders
Thylstrup, B., Bloomfield, K., & Hesse, M. (2017) · Addictive Behaviors · doi:10.1016/j.addbeh.2017.08.006 · Cited by 13
Self-citation
Factors Associated with Unplanned Early Discharges from a Dual Diagnosis Inpatient Detoxification Unit in Israel
Sofer, M. M., Kaptsan, A., & Anson, J. (2018) · Journal of Dual Diagnosis · doi:10.1080/15504263.2018.1461965 · Cited by 12
Parental alcohol use disorder with and without other mental disorders and offspring alcohol use disorder
Holst, C., Tolstrup, J. S., Sørensen, H. J., Pisinger, V. S. C., & Becker, U. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13002 · Cited by 14
Homelessness and Health Disparities: A Health Equity Lens
Bowen, E. A., Savino, R. F., & Irish, A. (2019) · Springer eBooks · doi:10.1007/978-3-030-03727-7_3 · Cited by 12
Co-occurrence of substance use related and mental health problems in the Finnish social and health care system
Kuussaari, K., & Hirschovits-Gerz, T. (2015) · Scandinavian Journal of Public Health · doi:10.1177/1403494815616303 · Cited by 12
Motivation deficits and use of alcohol and illicit drugs among individuals with schizophrenia
Bahorik, A. L., Greeno, C. G., Cochran, G., Cornelius, J. R., & Eack, S. M. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.04.012 · Cited by 13
Assessing evidence for seasonality of hospital admissions for schizophrenia in Queensland, Australia: a time series observational study
Jahan, S., Wraith, D., Dunne, M. P., & Naish, S. (2021) · International Journal of Biometeorology · doi:10.1007/s00484-021-02160-7 · Cited by 11
Patients with Schizophrenia Showed Worse Cognitive Performance than Bipolar and Major Depressive Disorder in a Sample with Comorbid Substance Use Disorders
Marquez-Arrico, J. E., Gonzalez-Sanchez, A., Navarro, J. F., Penadés, R., & Adán, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11226648 · Cited by 11
Temporal associations between medication adherence for patients with schizophrenia and opioid dependence: A 17-year Canadian Cohort Study
Rezansoff, S. N., Moniruzzaman, A., & Somers, J. M. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.05.031 · Cited by 11
Cognitive changes in patients with acute phase psychosis—Effects of illicit drug use
Helle, S., Gjestad, R., Johnsen, E., Kroken, R. A., Jørgensen, H. A., & Løberg, E. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.08.062 · Cited by 11
Examining the impact of substance use on hospital length of stay in schizophrenia spectrum disorder: a retrospective analysis
Burrer, A., Egger, S., Spiller, T. R., Kirschner, M., Homan, P., Seifritz, E., & Vetter, S. (2024) · BMC Medicine · doi:10.1186/s12916-024-03447-3 · Cited by 10
Differences in outpatient, emergency, and inpatient use among pregnant women with a substance-related diagnosis
Courchesne‐Krak, N. S., Kepner, W. E., Rubano, A., & Marienfeld, C. B. (2022) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2021.100559 · Cited by 10
Independent or Substance-Induced Mental Disorders? An Investigation of Comorbidity in an Acute Psychiatric Unit
Helseth, V., Samet, S., Johnsen, J. T., Bramness, J. G., & Waal, H. (2012) · Journal of Dual Diagnosis · doi:10.1080/15504263.2012.749142 · Cited by 10
Views of schizophrenia patients on the effects of cannabis on their mental health
Parshotam, R. K., & Joubert, P. (2015) · South African Journal of Psychiatry · doi:10.7196/sajp.590 · Cited by 14
Implementing clinical guidelines for co-occurring substance use and major mental disorders in Swedish forensic psychiatry: An exploratory, qualitative interview study with mental health care staff
Green, J., Bagge, A. S. L., Olausson, S., Andiné, P., Wallinius, M., & Karlén, M. H. (2023) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2022.108899 · Cited by 9
What Kind of Science for Dual Diagnosis? A Pragmatic Examination of the Enactive Approach to Psychiatry
Larsen, J. L., Johansen, K. S., & Mehlsen, M. Y. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.825701 · Cited by 9
Factors associated with the revolving door phenomenon in patients with schizophrenia: results from an acute psychiatric hospital in Romania
Dionisie, V., Puiu, M. G., Manea, M. C., Moisă, E., Dumitru, A. M., Ibadula, L., Mareș, A. M., Varlam, C. I., & Manea, M. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1496750 · Cited by 9
Outcome of patients with dual diagnosis in secondary psychiatric care
Luoto, K. E., Koivukangas, A., Lassila, A., & Kampman, O. (2016) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2016.1160149 · Cited by 9
Differential Effect of Community Rehabilitation Reform on Hospitalizations of Patients with Chronic Psychotic Disorders With and Without Substance Use Disorder, Israel, 1991–2016
Florentin, S., Neumark, Y. D., Raskin, S., Bdolah‐Abram, T., & Rosca, P. (2020) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-020-01077-4 · Cited by 9
Optimizing Substance Use Treatment Selection Using Reinforcement Learning
Baucum, M., Khojandi, A., Myers, C. R., & Kessler, L. M. (2022) · ACM Transactions on Management Information Systems · doi:10.1145/3563778 · Cited by 7
Quality of life among dually diagnosed and non-substance-using male schizophrenia outpatients
Aras, H. İ., Yazar, M. S., & Altınbaş, K. (2013) · South African Journal of Psychiatry · doi:10.4102/sajpsychiatry.v19i2.416 · Cited by 9
Polygenic liability for schizophrenia predicts shifting-specific executive function deficits and tobacco use in a moderate drinking community sample
Miller, A. P., Gizer, I. R., Fleming, W., Otto, J. M., Deak, J. D., Martins, J. S., & Bartholow, B. D. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.06.025 · Cited by 9
Prevalence, patterns, associated factors and severity of substance use among psychotic patients in southern Thailand
Tantirangsee, N., & Assanangkornchai, S. (2014) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2014.11.006 · Cited by 10
The influence of substance use on the effectiveness of antipsychotic medication: a prospective, pragmatic study
Alisauskiene, R., Løberg, E., Gjestad, R., Kroken, R. A., Jørgensen, H. A., & Johnsen, E. (2019) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2019.1622152 · Cited by 8
Genome-wide methylation analysis of treatment resistant schizophrenia
Luca, V. D., Chaudhary, Z., Al-Chalabi, N., Qian, J., Borlido, C., Gerretsen, P., Graff, A., Remington, G. J., & Chintoh, A. F. (2023) · Journal of Neural Transmission · doi:10.1007/s00702-022-02585-3 · Cited by 8
The European studies on mortality in schizophrenia
Gondek, T. M., Królicka, A., Piotrowski, P., & Kiejna, A. (2015) · Psychiatria Polska · doi:10.12740/pp/37845 · Cited by 8
Latent class profile of psychiatric symptoms and treatment utilization in a sample of patients with co-occurring disorders
Villalobos-Gallegos, L., Marín-Navarrete, R., Roncero, C., & González-Cantú, H. (2017) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2016-1972 · Cited by 8
Associations of comorbid substance use disorders with clinical outcomes in schizophrenia using electronic health record data
Patel, R., Chan, K. M. Y., Palmer, E. O. C., Valko, M., Guruswamy, G., Ker, S., Batra, G., Rentería, M. E., & Kollins, S. H. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.08.023 · Cited by 7
Substance use disorders before, at and after first episode psychosis hospitalizations in a young national Swedish cohort
Strålin, P., & Hetta, J. E. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.107919 · Cited by 7
Integrated Dual Disorder Treatment Implementation in a Large State Sample
Harrison, J., Curtis, A. B., Cousins, L. H., & Spybrook, J. K. (2016) · Community Mental Health Journal · doi:10.1007/s10597-016-0019-1 · Cited by 7

Authors: Schmidt, L. M., Hesse, M., & Lykke, J.
Affiliations: Sankt Hans Hospital (DK)
Venue: Schizophrenia Research
Publisher: Elsevier BV
Published: 2011-08
Volume: 130
Issue: 1-3
Pages: 228-233
ISSN: 0920-9964 (ISSN-L)
DOI: 10.1016/j.schres.2011.04.011
OpenAlex: W2022066531
Cited by: 171
References: 16
Citations by year: 2026: 6 · 2025: 7 · 2024: 10 · 2023: 8 · 2022: 12 · 2021: 10 · 2020: 13 · 2019: 13 · 2018: 15 · 2017: 15 · 2016: 12 · 2015: 11 · 2014: 10 · 2013: 17 · 2012: 10
FWCI: 8.53
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Schizophrenia Research (publishedVersion)
PubMed (publishedVersion)
Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Social Sciences › Sociology and Political Science › Homelessness and Social Issues
Keywords: schizophrenia, substance use disorders
MeSH terms: Adult, Aged, Aged, 80 and over, Cause of Death, Cross-Sectional Studies, Denmark, Female, Ill-Housed Persons, Humans, Longitudinal Studies, Male, Middle Aged, Predictive Value of Tests, Prognosis, Psychiatric Department, Hospital, Risk Factors, Schizophrenia, Time Factors, Diagnosis, Dual (Psychiatry), Substance-Related Disorders, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The impact of substance use disorders on the course of schizophrenia—A 15-year follow-up study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks